NESS-040C5
# NESS-040C5

NESS-040C5 is a potent cannabinoid agonist which was developed for the treatment of glaucoma. It has reasonable selectivity for the $CB_2$ receptor subtype, having a $CB_2$ affinity of 0.4nM, and 25x selectivity over the related $CB_1$ receptor.

